MP-PEG8-Val-Lys-Ala-7-MAD-MDCPT
MP-PEG8-Val-Lys-Ala-7-MAD-MDCPT is a agent-linker conjugate for antibody-drug conjugate (ADC) . MP-PEG8-Val-Lys-Ala-7-MAD-MDCPT has the potential for cancer and autoimmune disease research.
Product Specifications
CAS Number
2639190-44-4
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/mp-peg8-val-lys-ala-7-mad-mdcpt.html
Solubility
10 mM in DMSO
Smiles
O=C(C=CC1=O)N1CCC(NCCOCCOCCOCCOCCOCCOCCOCCOCCC(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(N[C@H](C)C(NCC2=C3C(C(N4C3)=CC([C@](O)(C(OC5)=O)CC)=C5C4=O)=NC6=CC(OCO7)=C7C=C62)=O)=O)=O)=O)=O
Molecular Formula
C62H87N9O21
Molecular Weight
1294.40
References & Citations
[1]Scott C. Jeffrey, et al. Camptothecin peptide conjugates. WO2021067861A1.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
Camptothecins
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog